Eiro, N.; Fraile, M.; González-Jubete, A.; González, L.O.; Vizoso, F.J.
Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. Int. J. Mol. Sci. 2022, 23, 8905.
https://doi.org/10.3390/ijms23168905
AMA Style
Eiro N, Fraile M, González-Jubete A, González LO, Vizoso FJ.
Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. International Journal of Molecular Sciences. 2022; 23(16):8905.
https://doi.org/10.3390/ijms23168905
Chicago/Turabian Style
Eiro, Noemi, Maria Fraile, Alberto González-Jubete, Luis O. González, and Francisco J. Vizoso.
2022. "Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges" International Journal of Molecular Sciences 23, no. 16: 8905.
https://doi.org/10.3390/ijms23168905
APA Style
Eiro, N., Fraile, M., González-Jubete, A., González, L. O., & Vizoso, F. J.
(2022). Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. International Journal of Molecular Sciences, 23(16), 8905.
https://doi.org/10.3390/ijms23168905